More than two sides of a coin? How to detect the multiple activities of type 2 transglutaminase

Carlo Rodolfo1, Laura Falasca, Giuseppina Di Giacomo

  • 1Department of Biology, University of Rome Tor Vergata, Rome, Italy.

Methods in Enzymology
|July 30, 2008
PubMed

Insights

Programmed cell death (PCD) involves precise gene regulation for cell elimination. Type 2 transglutaminase (TG2) is an early induced gene in PCD, but its multiple roles complicate its study.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Programmed cell death (PCD), or apoptosis, requires precise gene expression and protein activation for controlled cell removal.
  • Type 2 transglutaminase (TG2) is among the first genes identified as being induced during the initiation of PCD.
  • Since the late 1990s, TG2 has been found to possess diverse properties and enzymatic activities beyond PCD, increasing research complexity.

Purpose of the Study:

  • To elucidate the multifaceted roles of type 2 transglutaminase (TG2) in cellular processes.
  • To understand the complex regulation and functions of TG2, particularly its involvement in programmed cell death (PCD).

Main Methods:

  • Gene expression analysis during PCD.
  • Protein activation assays for TG2.
  • Enzymatic activity profiling of TG2.
  • Investigation of TG2's involvement in various cellular pathways.

Main Results:

  • TG2 expression and activation are tightly regulated during PCD.
  • TG2 participates in multiple cellular functions beyond its role in apoptosis.
  • The complex nature of TG2's activities presents challenges in fully characterizing its biological significance.

Conclusions:

  • TG2 is a key, early-induced gene in PCD with critical regulatory functions.
  • The diverse enzymatic activities of TG2 indicate its involvement in a broad spectrum of cellular processes.
  • Further research is essential to unravel the complete functional repertoire of TG2 and its implications in cell biology.

Related Concept Videos